薬局の市場規模、シェア、動向分析レポート：製品タイプ別、地域別、セグメント予測、2024年～2030年

薬局市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の薬局市場規模は2030年までに2兆600億米ドルに達し、2024年から2030年までのCAGRは7.28％で成長すると予測されています。

この背景には、処方薬支出の大部分を占める専門薬の使用動向や慢性疾患の蔓延による処方薬需要の増加があります。2022年9月の計画・評価担当次官補の統計によると、2021年には、米国の小売医薬品支出全体の40％以上、非小売医薬品支出の約70％を特殊医薬品が占めています。

近年、技術の進歩によって市場は大きく変化しています。最も大きな進歩のひとつは、電子カルテ（EHR）の利用です。EHRを利用することで、薬剤師は患者の医療情報にリアルタイムでアクセスし、更新することができます。これにより、処方箋記入の効率と正確性が向上し、ミスが減り、患者の安全性が向上しました。もう一つの進歩はロボット調剤システムで、処方箋を迅速かつ正確に充填することができるため、薬剤師は他の患者ケアサービスを提供する時間を確保することができます。テレファーマシーは、薬剤師が十分なサービスを受けていない地域の患者に遠隔で相談や処方箋記入サービスを提供することを可能にする、もう一つの新たな技術です。例えば、2020年11月、アマゾンは米国で処方薬を販売するアマゾンファーマシーを開始しました。薬局は、包装、ラベリング、充填、調剤に自動化システムやロボットを使用することで、効率を改善し、処方箋充填時間を短縮しています。

薬局市場レポートのハイライト

• 製品別では、処方箋分野が2023年に最大のシェアを占める。がん、糖尿病、心血管疾患などの慢性疾患の治療を目的とした医療専門家による処方箋数の増加が、同セグメントの成長を牽引すると予測されます。
• タイプ別では、小売薬局セグメントが2023年に最大の収益シェアを占めました。この成長の背景には、予防接種サービスや健康管理プログラムなど、処方箋調剤以外の様々なサービスを提供する独立薬局やチェーン店の増加があります。例えば、CVS Healthは糖尿病ケアや慢性腎臓病（CKD）管理などの健康管理プログラムを提供しており、市場拡大に貢献しています。
• 人口の高齢化、処方薬需要の増加、e-pharmacyサービスの導入増加などの要因により、2023年には北米が市場を独占しました。
• 2023年12月、Rite Aid Corpはフィラデルフィア・フライヤーズと提携しました。この提携は、ファンやアリーナを訪れる人々の間でフィラデルフィア・フライヤーズのブランド認知を強化することを目的としています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場の変数、動向、範囲

• 市場系統の見通し
  • 関連/補助市場見通し
• 市場動向と展望
• 市場力学
  • 市場 促進要因分析
  • 市場抑制要因分析
  • 業界の機会
  • 業界の課題
• ビジネス環境分析
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析
• COVID-19の影響分析

第4章 製品ビジネス分析

• 薬局市場：製品変動分析
• 製品市場：セグメントダッシュボード
• 製品の製品の動向と市場シェア分析、2023年および2030年
• 製品別
• 処方箋
• OTC

第5章 タイプビジネス分析

• 薬局市場：タイプの変動分析
• タイプ市場：セグメントダッシュボード
• タイプの動向と市場シェア分析、2023年および2030年
• タイプ別
• 病院薬局
• 小売薬局
• 電子薬局
• その他

第6章 地域ビジネス分析

• 地域別市場シェア分析、2023年および2030年
• 地域市場ダッシュボード
• 世界地域市場スナップショット
• 市場規模、予測動向分析、2018年-2030年
• 北米
  • 北米の薬局市場、2018年-2030年
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 欧州の薬局市場、2018年-2030年
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • スウェーデン
  • ノルウェー
  • デンマーク
• アジア太平洋地域
  • アジア太平洋地域の薬局市場、2018年-2030年
  • 日本
  • 中国
  • インド
  • オーストラリア
  • タイ
  • 韓国
• ラテンアメリカ
  • ラテンアメリカの薬局市場の推定・予測、2018年-2030年
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 中東・アフリカ薬局市場の推定・予測、2018-2030
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第7章 競合情勢

• 企業分類
• 戦略マッピング
  • 拡大
  • 合併と買収
  • 新サービス開始
  • パートナーシップ/コラボレーション
  • その他
• 企業の市況分析
• 企業プロファイル/上場企業
  • CVS Health
  • Boots Walgreens
  • Cigna
  • Walmart
  • Kroger
  • Rite Aid Corporation
  • Lloyd Pharmacy
  • Well Pharmacy
  • Humana Pharmacy Solutions
  • Matsumoto Kiyoshi
  • Apollo Pharmacy
  • MedPlusMart.com.

List of Tables

• Table 1 List of secondary sources
• Table 2 List of abbreviations
• Table 3 Global pharmacy market, by product, 2018 - 2030 (USD Billion)
• Table 4 Global pharmacy market, by type, 2018 - 2030 (USD Billion)
• Table 5 Global pharmacy market, by region, 2018 - 2030 (USD Billion)
• Table 6 North America pharmacy market, by country, 2018 - 2030 (USD Billion)
• Table 7 North America pharmacy market, by product, 2018 - 2030 (USD Billion)
• Table 8 North America pharmacy market, by type, 2018 - 2030 (USD Billion)
• Table 9 U.S.pharmacy market, by product, 2018 - 2030 (USD Billion)
• Table 10 U.S pharmacy market, by type, 2018 - 2030 (USD Billion)
• Table 11 Canada pharmacy market, by product, 2018 - 2030 (USD Billion)
• Table 12 Canada pharmacy market, by type, 2018 - 2030 (USD Billion)
• Table 13 Mexico pharmacy market, by product, 2018 - 2030 (USD Billion)
• Table 14 Mexico pharmacy market, by type, 2018 - 2030 (USD Billion)
• Table 15 Europe pharmacy market, by country, 2018 - 2030 (USD Billion)
• Table 16 Europe pharmacy market, by product, 2018 - 2030 (USD Billion)
• Table 17 Europe pharmacy market, by type, 2018 - 2030 (USD Billion)
• Table 18 UK pharmacy market, by product, 2018 - 2030 (USD Billion)
• Table 19 UK pharmacy market, by type, 2018 - 2030 (USD Billion)
• Table 20 Germany pharmacy market, by product, 2018 - 2030 (USD Billion)
• Table 21 Germany pharmacy market, by type, 2018 - 2030 (USD Billion)
• Table 22 France pharmacy market, by product, 2018 - 2030 (USD Billion)
• Table 23 France pharmacy market, by type, 2018 - 2030 (USD Billion)
• Table 24 Italy pharmacy market, by product, 2018 - 2030 (USD Billion)
• Table 25 Italy pharmacy market, by type, 2018 - 2030 (USD Billion)
• Table 26 Spain pharmacy market, by product, 2018 - 2030 (USD Billion)
• Table 27 Spain pharmacy market, by type, 2018 - 2030 (USD Billion)
• Table 28 Sweden pharmacy market, by product, 2018 - 2030 (USD Billion)
• Table 29 Sweden pharmacy market, by type, 2018 - 2030 (USD Billion)
• Table 30 Norway pharmacy market, by product, 2018 - 2030 (USD Billion)
• Table 31 Norway pharmacy market, by type, 2018 - 2030 (USD Billion)
• Table 32 Denmark pharmacy market, by product, 2018 - 2030 (USD Billion)
• Table 33 Denmark pharmacy market, by type, 2018 - 2030 (USD Billion)
• Table 34 Asia Pacific pharmacy market, by country, 2018 - 2030 (USD Billion)
• Table 35 Asia Pacific pharmacy market, by product, 2018 - 2030 (USD Billion)
• Table 36 Asia Pacific pharmacy market, by type, 2018 - 2030 (USD Billion)
• Table 37 Japan pharmacy market, by product, 2018 - 2030 (USD Billion)
• Table 38 Japan pharmacy market, by type, 2018 - 2030 (USD Billion)
• Table 39 China pharmacy market, by product, 2018 - 2030 (USD Billion)
• Table 40 China pharmacy market, by type, 2018 - 2030 (USD Billion)
• Table 41 India pharmacy market, by product, 2018 - 2030 (USD Billion)
• Table 42 India pharmacy market, by type, 2018 - 2030 (USD Billion)
• Table 43 Australia pharmacy market, by product, 2018 - 2030 (USD Billion)
• Table 44 Australia pharmacy market, by type, 2018 - 2030 (USD Billion)
• Table 45 Thailand pharmacy market, by product, 2018 - 2030 (USD Billion)
• Table 46 Thailand pharmacy market, by type, 2018 - 2030 (USD Billion)
• Table 47 South Korea pharmacy market, by product, 2018 - 2030 (USD Billion)
• Table 48 South Korea pharmacy market, by type, 2018 - 2030 (USD Billion)
• Table 49 Latin America pharmacy market, by country, 2018 - 2030 (USD Billion)
• Table 50 Latin America pharmacy market, by product, 2018 - 2030 (USD Billion)
• Table 51 Latin America pharmacy market, by type, 2018 - 2030 (USD Billion)
• Table 52 Brazil pharmacy market, by product, 2018 - 2030 (USD Billion)
• Table 53 Brazil pharmacy market, by type, 2018 - 2030 (USD Billion)
• Table 54 Argentina pharmacy market, by product, 2018 - 2030 (USD Billion)
• Table 55 Argentina pharmacy market, by type, 2018 - 2030 (USD Billion)
• Table 56 Middle East & Africa pharmacy market, by country, 2018 - 2030 (USD Billion)
• Table 57 Middle East & Africa pharmacy market, by product, 2018 - 2030 (USD Billion)
• Table 58 Middle East & Africa pharmacy market, by type, 2018 - 2030 (USD Billion)
• Table 59 South Africa pharmacy market, by product, 2018 - 2030 (USD Billion)
• Table 60 South Africa pharmacy market, by type, 2018 - 2030 (USD Billion)
• Table 61 Saudi Arabia pharmacy market, by product, 2018 - 2030 (USD Billion)
• Table 62 Saudi Arabia pharmacy market, by type, 2018 - 2030 (USD Billion)
• Table 63 UAE pharmacy market, by product, 2018 - 2030 (USD Billion)
• Table 64 UAE pharmacy market, by type, 2018 - 2030 (USD Billion)
• Table 65 Kuwait pharmacy market, by product, 2018 - 2030 (USD Billion)
• Table 66 Kuwait pharmacy market, by type, 2018 - 2030 (USD Billion)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Pharmacy market segmentation
• Fig. 3 Market research process
• Fig. 4 Data triangulation techniques
• Fig. 5 Primary research pattern
• Fig. 6 Market research approaches
• Fig. 7 Value-chain-based sizing & forecasting
• Fig. 8 QFD modelling for market share assessment
• Fig. 9 Market formulation & validation
• Fig. 10 Market snapshot
• Fig. 11 Market segmentation
• Fig. 12 Competitive landscape
• Fig. 13 Global pharmacy market lineage outlook
• Fig. 14 Pharmacy market dynamics
• Fig. 15 Market driver relevance analysis (Current & future impact)
• Fig. 16 Market restraint relevance analysis (Current & future impact)
• Fig. 17 Pharmacy market: Porter's five forces analysis
• Fig. 18 Pharmacy market: PESTLE analysis
• Fig. 19 Pharmacy market product outlook: Segment dashboard
• Fig. 20 Pharmacy market: Product movement & market share analysis, 2023 & 2030
• Fig. 21 Prescription market, 2018 - 2030 (USD Million)
• Fig. 22 OTC market, 2018 - 2030 (USD Million)
• Fig. 23 Pharmacy market type outlook: Segment dashboard)
• Fig. 24 Pharmacy market: type movement & market share analysis, 2023 & 2030
• Fig. 25 Hospital pharmacy market, 2018 - 2030 (USD Billion)
• Fig. 26 Retail pharmacy market, 2018 - 2030 (USD Billion)
• Fig. 27 Chain pharmacy market, 2018 - 2030 (USD Billion)
• Fig. 28 Independent pharmacy market, 2018 - 2030 (USD Billion)
• Fig. 29 Other retail pharmacy market, 2018 - 2030 (USD Billion)
• Fig. 30 ePharmacy market, 2018 - 2030 (USD Billion)
• Fig. 31 Other pharmacy market, 2018 - 2030 (USD Billion)
• Fig. 32 Regional marketplace: Key takeaways
• Fig. 33 North America pharmacy market, 2018 - 2030 (USD Billion)
• Fig. 34 U.S key country dynamics
• Fig. 35 U.S pharmacy market, 2018 - 2030 (USD Billion)
• Fig. 36 Canada key country dynamics
• Fig. 37 Canada pharmacy market, 2018 - 2030 (USD Billion)
• Fig. 38 Mexico key country dynamic
• Fig. 39 Mexico pharmacy market, 2018 - 2030 (USD Billion)
• Fig. 40 Europe pharmacy market, 2017 - 2030 (USD Billion)
• Fig. 41 UK key country dynamic
• Fig. 42 UK pharmacy market, 2018 - 2030 (USD Billion)
• Fig. 43 Germany key country dynamic
• Fig. 44 Germany pharmacy market, 2018 - 2030 (USD Billion)
• Fig. 45 France key country dynamic
• Fig. 46 France pharmacy market, 2018 - 2030 (USD Billion)
• Fig. 47 Italy key country dynamic
• Fig. 48 Italy pharmacy market, 2018 - 2030 (USD Billion)
• Fig. 49 Spain key country dynamic
• Fig. 50 Spain pharmacy market, 2018 - 2030 (USD Billion)
• Fig. 51 Denmark key country dynamic
• Fig. 52 Denmark pharmacy market, 2018 - 2030 (USD Billion)
• Fig. 53 Sweden key country dynamic
• Fig. 54 Sweden pharmacy market, 2018 - 2030 (USD Billion)
• Fig. 55 Norway key country dynamic
• Fig. 56 Norway pharmacy market, 2018 - 2030 (USD Billion)
• Fig. 57 Asia Pacific pharmacy market, 2018 - 2030 (USD Billion)
• Fig. 58 China key country dynamic
• Fig. 59 China pharmacy market, 2018 - 2030 (USD Billion)
• Fig. 60 Japan key country dynamic
• Fig. 61 Japan pharmacy market, 2018 - 2030 (USD Billion)
• Fig. 62 India key country dynamic
• Fig. 63 India pharmacy market, 2018 - 2030 (USD Billion)
• Fig. 64 South Korea key country dynamic
• Fig. 65 South Korea pharmacy market, 2018 - 2030 (USD Billion)
• Fig. 66 Australia key country dynamic
• Fig. 67 Australia pharmacy market, 2018 - 2030 (USD Billion)
• Fig. 68 Thailand key country dynamic
• Fig. 69 Thailand pharmacy market, 2018 - 2030 (USD Billion)
• Fig. 70 Latin America pharmacy market, 2018 - 2030 (USD Billion)
• Fig. 71 Brazil key country dynamic
• Fig. 72 Brazil pharmacy market, 2018 - 2030 (USD Billion)
• Fig. 73 Argentina key country dynamic
• Fig. 74 Argentina pharmacy market, 2018 - 2030 (USD Billion)
• Fig. 75 MEA pharmacy market, 2018 - 2030 (USD Billion)
• Fig. 76 South Africa key country dynamic
• Fig. 77 South Africa pharmacy market, 2018 - 2030 (USD Billion)
• Fig. 78 Saudi Arabia key country dynamic
• Fig. 79 Saudi Arabia pharmacy market, 2018 - 2030 (USD Billion)
• Fig. 80 UAE key country dynamic
• Fig. 81 UAE pharmacy market, 2018 - 2030 (USD Billion)
• Fig. 82 Kuwait key country dynamic
• Fig. 83 Kuwait pharmacy market, 2018 - 2030 (USD Billion)
• Fig. 84 Company categorization
• Fig. 85 Company market position analysis
• Fig. 86 Strategic framework

Pharmacy Market Growth & Trends:

The global pharmacy market size is anticipated to reach USD 2.06 trillion by 2030, growing at a CAGR of 7.28% from 2024 to 2030, according to a new report by Grand View Research, Inc. This can be attributed to the growing demand for prescription medications due to a trend towards the use of specialty medications, which account for a significant portion of prescription drug spending, and the increasing prevalence of chronic diseases. According to the Assistant Secretary for Planning and Evaluation statistics of September 2022, in 2021, specialty drugs accounted for more than 40% of overall retail drug spending and around 70% of the no-retail drug spending in the U.S.

Technological advancements have transformed the market in recent years. One of the most significant advancements is using Electronic Health Records (EHRs), which allow pharmacists to access and update patient medical information in real-time. This has improved the efficiency and accuracy of prescription filling, reduced errors, and improved patient safety. Another advancement is robotic dispensing systems, which can fill prescriptions quickly & accurately, freeing up time for pharmacists to provide additional patient care services. Telepharmacy is another emerging technology that allows pharmacists to provide remote consultations and prescription filling services to patients in underserved areas. For instance, in November 2020, Amazon launched Amazon Pharmacy to sell prescription drugs in the U.S. Pharmacies are using automation systems and robots for packaging, labeling, filling, and dispensing to improve efficiency and reduce prescription filling time.

Pharmacy Market Report Highlights:

• Based on product, prescription segment held the largest share in 2023. The growing number of prescriptions by healthcare professionals for the treatment of chronic conditions such as cancer, diabetes, and cardiovascular diseases is expected to drive the growth of the segment.
• Based on type, the retail pharmacy segment accounted for the largest revenue share in 2023. This growth is attributed to the increasing number of independent pharmacies and chains offering various services beyond prescription dispensing, such as vaccination services and health management programs. For instance, CVS Health provides health management programs such as diabetes care and chronic kidney disease (CKD) management, contributing to market expansion.
• North America dominated the market in 2023 due to factors such as the aging population, increasing demand for prescription medications, and the rise in the adoption of e-pharmacy services.
• In December 2023, Rite Aid Corp partnered with the Philadelphia Flyers. This partnership aimed to help strengthen Philadelphia Flyer's brand awareness among fans and visitors to the arena.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Market Definitions
• 1.2. Regional Scope
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources & Third-Party Perspectives
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
  • 1.8.2. Volume Price Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Related/Ancillary Market Outlook
• 3.2. Market Trends and Outlook
• 3.3. Market Dynamics
  • 3.3.1. Market Driver Analysis
    • 3.3.1.1. Increasing prevalence of chronic diseases
    • 3.3.1.2. Expanding health insurance coverage
    • 3.3.1.3. Technological advancement
    • 3.3.1.4. Increasing demand for specialty drugs
  • 3.3.2. Market Restraint Analysis
    • 3.3.2.1. Product Recalls and Lawsuits
    • 3.3.2.2. Lack of trained staff
  • 3.3.3. Industry Opportunities
  • 3.3.4. Industry Challenges
• 3.4. Business Environment Analysis
  • 3.4.1. Industry Analysis - Porter's Five Forces Analysis
    • 3.4.1.1. Supplier power
    • 3.4.1.2. Buyer power
    • 3.4.1.3. Substitution threat
    • 3.4.1.4. Threat of new entrant
    • 3.4.1.5. Competitive rivalry
  • 3.4.2. PESTEL Analysis
• 3.5. COVID-19 Impact Analysis

Chapter 4. Product Business Analysis

• 4.1. Pharmacy Market: Product Movement Analysis
• 4.2. Pharmacy Product Market: Segment Dashboard
• 4.3. Product Movement & Market Share Analysis, 2023 & 2030
• 4.4. Global Pharmacy Market Estimates & Forecast, by Product
• 4.5. Prescription
  • 4.5.1. Prescription market, 2018 - 2030 (USD Billion)
• 4.6. OTC
  • 4.6.1. OTC market, 2018 - 2030 (USD Billion)

Chapter 5. Type Business Analysis

• 5.1. Pharmacy Market: Type Movement Analysis
• 5.2. Type Market: Segment Dashboard
• 5.3. Type Movement & Market Share Analysis, 2023 & 2030
• 5.4. Global Pharmacy Market Estimates & Forecast, by Type
• 5.5. Hospital Pharmacy
  • 5.5.1. Hospital Pharmacy market, 2018 - 2030 (USD Billion)
• 5.6. Retail Pharmacy
  • 5.6.1. Retail Pharmacy market, 2018 - 2030 (USD Billion)
  • 5.6.2. Chain
    • 5.6.2.1. Chain Pharmacy market, 2018 - 2030 (USD Billion)
  • 5.6.3. Independent pharmacy
    • 5.6.3.1. Independent pharmacy market, 2018 - 2030 (USD Billion)
  • 5.6.4. Others
    • 5.6.4.1. Others market, 2018 - 2030 (USD Billion)
• 5.7. ePharmacy
  • 5.7.1. ePharmacy market, 2018 - 2030 (USD Billion)
• 5.8. Others
  • 5.8.1. Others market, 2018 - 2030 (USD Billion)

Chapter 6. Regional Business Analysis

• 6.1. Regional Market Share Analysis, 2023 & 2030
• 6.2. Regional Market Dashboard
• 6.3. Global Regional Market Snapshot
• 6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 6.5. North America
  • 6.5.1. North America Pharmacy Market, 2018 - 2030 (USD Billion)
  • 6.5.2. U.S.
    • 6.5.2.1. Key country dynamics
    • 6.5.2.2. Regulatory framework
    • 6.5.2.3. Competitive scenario
    • 6.5.2.4. U.S. pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
  • 6.5.3. Canada
    • 6.5.3.1. Key country dynamics
    • 6.5.3.2. Regulatory framework
    • 6.5.3.3. Competitive scenario
    • 6.5.3.4. Canada pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
  • 6.5.4. Mexico
    • 6.5.4.1. Key country dynamics
    • 6.5.4.2. Regulatory framework
    • 6.5.4.3. Competitive scenario
    • 6.5.4.4. Mexico pharmacy market estimates & forecast,, 2018 - 2030 (USD Billion)
• 6.6. Europe
  • 6.6.1. Europe Pharmacy Market, 2018 - 2030 (USD Billion)
  • 6.6.2. UK
    • 6.6.2.1. Key country dynamics
    • 6.6.2.2. Regulatory framework
    • 6.6.2.3. Competitive scenario
    • 6.6.2.4. UK pharmacy market estimates & forecast,, 2018 - 2030 (USD Billion)
  • 6.6.3. Germany
    • 6.6.3.1. Key country dynamics
    • 6.6.3.2. Regulatory framework
    • 6.6.3.3. Competitive scenario
    • 6.6.3.4. Germany pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
  • 6.6.4. France
    • 6.6.4.1. Key country dynamics
    • 6.6.4.2. Regulatory framework
    • 6.6.4.3. Competitive scenario
    • 6.6.4.4. France pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
  • 6.6.5. Italy
    • 6.6.5.1. Key country dynamics
    • 6.6.5.2. Regulatory framework
    • 6.6.5.3. Competitive scenario
    • 6.6.5.4. Italy pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
  • 6.6.6. Spain
    • 6.6.6.1. Key country dynamics
    • 6.6.6.2. Regulatory framework
    • 6.6.6.3. Competitive scenario
    • 6.6.6.4. Spain pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
  • 6.6.7. Sweden
    • 6.6.7.1. Key country dynamics
    • 6.6.7.2. Regulatory framework
    • 6.6.7.3. Competitive scenario
    • 6.6.7.4. Sweden pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
  • 6.6.8. Norway
    • 6.6.8.1. Key country dynamics
    • 6.6.8.2. Regulatory framework
    • 6.6.8.3. Competitive scenario
    • 6.6.8.4. Norway pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
  • 6.6.9. Denmark
    • 6.6.9.1. Key country dynamics
    • 6.6.9.2. Regulatory framework
    • 6.6.9.3. Competitive scenario
    • 6.6.9.4. Denmark pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
• 6.7. Asia Pacific
  • 6.7.1. Asia Pacific Pharmacy Market, 2018 - 2030 (USD Billion)
  • 6.7.2. Japan
    • 6.7.2.1. Key country dynamics
    • 6.7.2.2. Regulatory framework
    • 6.7.2.3. Competitive scenario
    • 6.7.2.4. Japan pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
  • 6.7.3. China
    • 6.7.3.1. Key country dynamics
    • 6.7.3.2. Regulatory framework
    • 6.7.3.3. Competitive scenario
    • 6.7.3.4. China pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
  • 6.7.4. India
    • 6.7.4.1. Key country dynamics
    • 6.7.4.2. Regulatory framework
    • 6.7.4.3. Competitive scenario
    • 6.7.4.4. India pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
  • 6.7.5. Australia
    • 6.7.5.1. Key country dynamics
    • 6.7.5.2. Regulatory framework
    • 6.7.5.3. Competitive scenario
    • 6.7.5.4. Australia pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
  • 6.7.6. Thailand
    • 6.7.6.1. Key country dynamics
    • 6.7.6.2. Regulatory framework
    • 6.7.6.3. Competitive scenario
    • 6.7.6.4. Thailand pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
  • 6.7.7. South Korea
    • 6.7.7.1. Key country dynamics
    • 6.7.7.2. Regulatory framework
    • 6.7.7.3. Competitive scenario
    • 6.7.7.4. South Korea pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
• 6.8. Latin America
  • 6.8.1. Latin America Pharmacy Market Estimates & Forecast, 2018 - 2030 (USD Billion)
  • 6.8.2. Brazil
    • 6.8.2.1. Key country dynamics
    • 6.8.2.2. Regulatory framework
    • 6.8.2.3. Competitive scenario
    • 6.8.2.4. Brazil pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
  • 6.8.3. Argentina
    • 6.8.3.1. Key country dynamics
    • 6.8.3.2. Regulatory framework
    • 6.8.3.3. Competitive scenario
    • 6.8.3.4. Argentina pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
• 6.9. MEA
  • 6.9.1. MEA Pharmacy Market Estimates & Forecast, 2018 - 2030 (USD Billion)
  • 6.9.2. South Africa
    • 6.9.2.1. Key country dynamics
    • 6.9.2.2. Regulatory framework
    • 6.9.2.3. Competitive scenario
    • 6.9.2.4. South Africa pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
  • 6.9.3. Saudi Arabia
    • 6.9.3.1. Key country dynamics
    • 6.9.3.2. Regulatory framework
    • 6.9.3.3. Competitive scenario
    • 6.9.3.4. Saudi Arabia pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
  • 6.9.4. UAE
    • 6.9.4.1. Key country dynamics
    • 6.9.4.2. Regulatory framework
    • 6.9.4.3. Competitive scenario
    • 6.9.4.4. UAE pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
  • 6.9.5. Kuwait
    • 6.9.5.1. Key country dynamics
    • 6.9.5.2. Regulatory framework
    • 6.9.5.3. Competitive scenario
    • 6.9.5.4. Kuwait pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)

Chapter 7. Competitive Landscape

• 7.1. Company Categorization
• 7.2. Strategy Mapping
  • 7.2.1. Expansion
  • 7.2.2. Merger & Acquisition
  • 7.2.3. New Service Launch
  • 7.2.4. Partnership/Collaborations
  • 7.2.5. Others
• 7.3. Company market position analysis
• 7.4. Company Profiles/Listing
  • 7.4.1. CVS Health
    • 7.4.1.1. Overview
    • 7.4.1.2. Financial Performance
    • 7.4.1.3. Service Benchmarking
    • 7.4.1.4. Strategic Initiatives
  • 7.4.2. Boots Walgreens
    • 7.4.2.1. Overview
    • 7.4.2.2. Financial Performance
    • 7.4.2.3. Service Benchmarking
    • 7.4.2.4. Strategic Initiatives
  • 7.4.3. Cigna
    • 7.4.3.1. Overview
    • 7.4.3.2. Financial Performance
    • 7.4.3.3. Service Benchmarking
    • 7.4.3.4. Strategic Initiatives
  • 7.4.4. Walmart
    • 7.4.4.1. Overview
    • 7.4.4.2. Financial Performance
    • 7.4.4.3. Service Benchmarking
    • 7.4.4.4. Strategic Initiatives
  • 7.4.5. Kroger
    • 7.4.5.1. Overview
    • 7.4.5.2. Financial Performance
    • 7.4.5.3. Service Benchmarking
    • 7.4.5.4. Strategic Initiatives
  • 7.4.6. Rite Aid Corporation
    • 7.4.6.1. Overview
    • 7.4.6.2. Financial Performance
    • 7.4.6.3. Service Benchmarking
    • 7.4.6.4. Strategic Initiatives
  • 7.4.7. Lloyd Pharmacy
    • 7.4.7.1. Overview
    • 7.4.7.2. Financial Performance
    • 7.4.7.3. Service Benchmarking
    • 7.4.7.4. Strategic Initiatives
  • 7.4.8. Well Pharmacy
    • 7.4.8.1. Overview
    • 7.4.8.2. Financial Performance
    • 7.4.8.3. Service Benchmarking
    • 7.4.8.4. Strategic Initiatives
    • 7.4.8.5. Strategic Initiatives
  • 7.4.9. Humana Pharmacy Solutions
    • 7.4.9.1. Overview
    • 7.4.9.2. Financial Performance
    • 7.4.9.3. Service Benchmarking
    • 7.4.9.4. Strategic Initiatives
  • 7.4.10. Matsumoto Kiyoshi
    • 7.4.10.1. Overview
    • 7.4.10.2. Financial Performance
    • 7.4.10.3. Service Benchmarking
    • 7.4.10.4. Strategic Initiatives
  • 7.4.11. Apollo Pharmacy
    • 7.4.11.1. Overview
    • 7.4.11.2. Financial Performance
    • 7.4.11.3. Service Benchmarking
    • 7.4.11.4. Strategic Initiatives
  • 7.4.12. MedPlusMart.com.
    • 7.4.12.1. Overview
    • 7.4.12.2. Financial Performance
    • 7.4.12.3. Service Benchmarking
    • 7.4.12.4. Strategic Initiatives